221 related articles for article (PubMed ID: 11219775)
21. Estrogen receptor in breast ductal carcinoma in situ: good cop, bad cop?
DeCensi A; Pruneri G; Guerrieri-Gonzaga A
J Clin Oncol; 2012 Apr; 30(12):1384-6. PubMed ID: 22393083
[No Abstract] [Full Text] [Related]
22. Tumour markers in breast carcinoma correlate with grade rather than with invasiveness.
Wärnberg F; Nordgren H; Bergkvist L; Holmberg L
Br J Cancer; 2001 Sep; 85(6):869-74. PubMed ID: 11556839
[TBL] [Abstract][Full Text] [Related]
23. [Recent advances in studies on in-situ and invasive ductal carcinoma].
Zhang RJ; Niu Y; Gao YX
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):63-5. PubMed ID: 19489232
[No Abstract] [Full Text] [Related]
24. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.
Nielsen BS; Rank F; López JM; Balbin M; Vizoso F; Lund LR; Danø K; López-Otín C
Cancer Res; 2001 Oct; 61(19):7091-100. PubMed ID: 11585740
[TBL] [Abstract][Full Text] [Related]
25. Common questions about ductal carcinoma in situ.
Dell DD
Am J Nurs; 1997 May; 97(5):61-3, 65-6. PubMed ID: 9155799
[No Abstract] [Full Text] [Related]
26. [Expression of alpha-tubulin and gamma-tubulin in premalignant lesion and carcinoma of breast and the significance thereof].
Niu Y; Wang Y; Yu Y; Ding XM; Lü SH; Xiao XQ
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):56-60. PubMed ID: 16606540
[TBL] [Abstract][Full Text] [Related]
27. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
28. Contemporary diagnostic approaches for nonpalpable carcinoma of the breast: the role of the radiologist.
Schepps B; Scola FH
R I Med; 1995 Sep; 78(9):239-41. PubMed ID: 7579717
[TBL] [Abstract][Full Text] [Related]
29. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component.
Konar K; Chatterjee U; Dutta SK
Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916
[TBL] [Abstract][Full Text] [Related]
30. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ.
Helczynska K; Kronblad A; Jögi A; Nilsson E; Beckman S; Landberg G; Påhlman S
Cancer Res; 2003 Apr; 63(7):1441-4. PubMed ID: 12670886
[TBL] [Abstract][Full Text] [Related]
31. Increased estrogen receptor betacx expression during mammary carcinogenesis.
Esslimani-Sahla M; Kramar A; Simony-Lafontaine J; Warner M; Gustafsson JA; Rochefort H
Clin Cancer Res; 2005 May; 11(9):3170-4. PubMed ID: 15867209
[TBL] [Abstract][Full Text] [Related]
32. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer.
Jang KS; Han HX; Paik SS; Brown PH; Kong G
Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432
[TBL] [Abstract][Full Text] [Related]
33. The estrogen receptors alpha, beta, and beta cx.
Shaaban AM; Speirs V
Clin Cancer Res; 2005 Nov; 11(22):8222; author reply 8222-3. PubMed ID: 16299256
[No Abstract] [Full Text] [Related]
34. A confusing cancer.
Health News; 1998 Aug; 4(10):1-2. PubMed ID: 9708039
[No Abstract] [Full Text] [Related]
35. Ductal carcinoma in situ with periductal fibrosis -- is it in reality an invasive carcinoma?
Naresh KN; Borges AM
Hum Pathol; 1996 Jul; 27(7):744. PubMed ID: 8698323
[No Abstract] [Full Text] [Related]
36. Cytologic characteristics of endocrine ductal carcinoma in situ of the breast. A case report.
Yin H; Schinella R
Acta Cytol; 2002; 46(5):873-6. PubMed ID: 12365222
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of selected immunohistochemical parameters in patients with invasive breast carcinoma concomitant with ductal carcinoma in situ.
Patla A; Rudnicka-Sosin L; Pawlega J; Stachura J
Pol J Pathol; 2002; 53(1):25-7. PubMed ID: 12014222
[TBL] [Abstract][Full Text] [Related]
38. Sentinel lymph node biopsy for breast cancer.
Swanson JO
J Insur Med; 2001; 33(2):195-7. PubMed ID: 11510518
[TBL] [Abstract][Full Text] [Related]
39. Atypia and Ki-67 expression from ductal lavage in women at different risk for breast cancer.
Cazzaniga M; Severi G; Casadio C; Chiapparini L; Veronesi U; Decensi A
Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1311-5. PubMed ID: 16835329
[TBL] [Abstract][Full Text] [Related]
40. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
Reinier KS; Vacek PM; Geller BM
Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
